FDA to Host Joint Meeting of Pulmonary-Allergy Drugs and Endocrinologic and Metabolic Drugs Advisory Committees

Summary

The US Food and Drug Administration (FDA) will convene a joint meeting of its Pulmonary-Allergy Drugs and Endocrinologic and Metabolic Drugs Advisory Committees to discuss various topics related to these drug categories, as announced in a recent notice published on the FDA website (https://www.fda.gov/medwatch/ucm-857-035-000-001).